Nigeria Gets Twice-Yearly HIV Prevention Shot for 52,000

For thousands of Nigerians at risk of HIV, protection just got simpler and more private.

Nigeria has received 52,000 doses of Lenacapavir, a long-acting injection that prevents HIV infection with just two shots per year. The country is one of only nine nations selected by the Global Fund to roll out this breakthrough prevention tool.

Dr. Iziaq Salako, Nigeria's Minister of State for Health, called it "a major milestone" that will expand prevention options beyond daily pills. For people facing stigma or struggling with daily medication routines, the twice-yearly option offers both convenience and discretion.

The rollout begins in eight states: Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, Benue, and the Federal Capital Territory. These locations were chosen based on HIV prevalence rates and readiness to implement the new program.

Nigeria's health ministry has already developed policy guidelines and implementation plans to support the launch. The injectable medication will complement existing prevention methods like oral PrEP, giving people more choices based on their lifestyles and needs.

Health officials were quick to clarify what Lenacapavir can and cannot do. It prevents HIV infection but does not protect against other sexually transmitted infections, hepatitis, or pregnancy, and it's not recommended for pregnant women.

Dr. Temitope Ilori, Director-General of Nigeria's National Agency for the Control of AIDS, noted that while global data shows the drug is highly safe, more research is needed on its use during pregnancy. The focus remains on offering it to populations at substantial risk of HIV infection.

The Ripple Effect

This injection arrives at a crucial moment for Nigeria's fight against HIV. The country aims to end AIDS as a public health threat by 2030, and expanding prevention access is key to reaching that goal.

For vulnerable populations who may face barriers to daily pill regimens, whether due to housing instability, privacy concerns, or simply pill fatigue, a twice-yearly injection removes significant obstacles. Freedom from daily reminders of risk can reduce stress and improve quality of life.

Dr. Adebobola Bashorun, National Coordinator of Nigeria's HIV control program, confirmed plans to expand access beyond the initial eight states. The government is actively seeking funding to increase doses and reach more people at risk.

Representatives from the Global Fund and World Health Organization praised Nigeria's swift action, calling the rollout a critical turning point in HIV prevention. Their support signals confidence in Nigeria's ability to deliver this new tool effectively.

For a country working hard to reduce new infections, giving 52,000 people a simpler path to protection is progress worth celebrating.